Results 31 to 40 of about 344,100 (302)
ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential
Pharmaceuticals, 2021 On 11 March 2020, the World Health Organization (WHO) classified the Coronavirus Disease 2019 (COVID-19) as a global pandemic, which tested healthcare systems, administrations, and treatment ingenuity across the world.
Subrata Deb +3 more
doaj +1 more source
Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity [PDF]
, 2020 On 7 January 2020, researchers isolated and sequenced in China from patients with severe pneumonitis a novel coronavirus, then called SARS-CoV-2, which rapidly spread worldwide, becoming a global health emergency.
Diamanti, A. P. +4 more
core +2 more sources
Different COVID-19 treatments’ impact on hospital length of stay
European Journal of Medical Research, 2023 Importance COVID-19 has adversely affected global healthcare infrastructure since 2019. Currently, there are no large-scale published reports on the efficacy of combination therapy of dexamethasone, remdesivir, and tocilizumab on COVID-19 patients ...
Satori Iwamoto +8 more
doaj +1 more source
Pharmaceutical Sciences and Research, 2020 Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and can be aggravated by comorbid diseases.
Ana Khusnul Faizah +2 more
doaj +1 more source
Repurposing Existing Drugs for the Treatment of COVID-19
Annals of the American Thoracic Society, 2020 The rapid global spread and significant mortality associated with the coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection has spurred an urgent race to find effective treatments. Repurposing existing drugs is a particularly attractive approach as pharmacokinetic and safety data already ...
Hugo Farne +5 more
openaire +4 more sources
Natural products as environmentally safe and green approach to combat Covid-19
Current Research in Green and Sustainable Chemistry, 2021 The Covid-19 pandemic is a major catastrophe in recent times that has taken a toll over the global scale in terms of the casualties, economic impact, and human beings' lifestyle.
Dheeraj Singh Chauhan +2 more
doaj +1 more source
Drug treatment for Covid-19 - three years later
Infectious Diseases Now, 2023 There has been a profusion of trials for SARS CoV2 drugs. A review dating from May 2020 listed 115 medicines, most of which previously existed, having been investigated since the onset of the pandemic. Over an exceedingly short lapse of time, the perspective of the arrival of a new antiviral treatment specifically targeting COVID-19 appeared highly ...
openaire +2 more sources
COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions [PDF]
British Journal of Clinical Pharmacology, 2020 In a recent issue of Br J Clin Pharmacol Smith et al1 published an outstanding commentary titled ‘Dosing will be a key success factor in repurposing antivirals for Covid-19’. They highlighted that the success in our repurposing efforts will be dependent on ‘getting the dose right’ for drugs which have been developed for different indications and ...
Back, David +7 more
openaire +7 more sources
Identifying side effects of commonly used drugs in the treatment of Covid 19
Scientific Reports, 2020 To increase the success in Covid 19 treatment, many drug suggestions are presented, and some clinical studies are shared in the literature. There have been some attempts to use some of these drugs in combination.
İrfan Aygün, Mehmet Kaya, Reda Alhajj
doaj +1 more source
Drug interactions of ivermectin with a focus on COVID-19 treatment
Muller Journal of Medical Sciences and Research, 2021 Treatment of COVID-19 largely depends on previously used drugs as there is no cure available coupled with shortage of effective vaccine with doubts about its long-term protection due to rapid viral mutations.
Padmaja Udaykumar +2 more
doaj +1 more source